Pearl River Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Pearl River Capital, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $2.09 Million - $2.55 Million	-3,019 Reduced 44.18%	3,814 $3.14 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $4.78 Million - $5.67 Million	6,833 New	6,833 $4.91 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $511,064 - $554,866	-724 Reduced 19.87%	2,919 $2.11 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $984,358 - $1.24 Million	-1,715 Reduced 32.01%	3,643 $2.51 Million
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $2.94 Million - $3.96 Million	5,358 New	5,358 $3.17 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $2.04 Million - $2.39 Million	-3,420 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $1.86 Million - $2.29 Million	3,420 New	3,420 $2.16 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $2.15 Million - $2.54 Million	-4,548 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $496,763 - $609,598	1,112 Added 32.36%	4,548 $2.15 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $1.64 Million - $2.09 Million	3,436 New	3,436 $1.66 Million
Q2 2020 Aug 10, 2020	SELL	$493.32 - $643.92 $76,957 - $100,451	-156 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$336.18 - $494.43 $52,444 - $77,131	156 New	156 $76,000
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $85,319 - $99,337	-312 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $93,475 - $129,423	312 New	312 $98,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.